Pedobarometric evaluation of equinus foot disorder after injection of botulinum toxin A in children with cerebral palsy: A pilot study

Developmental Medicine and Child Neurology

Volumn 47, Issue 6, 2005, Pages 396-402

  Falso, Maurizio ^a   Fiaschi, A ^a   Manganotti, P ^a  

^a G B ROSSI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ARTICLE; BODY MASS; BODY POSTURE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; HEMIPLEGIA; HUMAN; JOINT STABILITY; LEG MOVEMENT; MALE; MOBILIZATION; PES EQUINUS; PILOT STUDY; PLANTARIS MUSCLE; PRIORITY JOURNAL; RATING SCALE; SPASTICITY; STANDING; STUDENT T TEST;

ADOLESCENT; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; DISABILITY EVALUATION; EQUINUS DEFORMITY; FEMALE; FOLLOW-UP STUDIES; FOOT; HUMANS; MALE; NEUROMUSCULAR AGENTS; ORTHOPEDIC PROCEDURES; PILOT PROJECTS; RANGE OF MOTION, ARTICULAR; TIME FACTORS; TREATMENT OUTCOME;

EID: 19644362057     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0012162205000770     Document Type: Article

References (36)

1. Alexander IJ, Chao EYS, Johnson KA. (1990) The assessment of dynamic foot to ground contact forces and plantar pressure distribution: a review of the evolution of current techniques and clinical applications. Foot Ankle 11: 152-167.
2. Banks HH. (1977) The management of spastic deformities of the foot and ankle. Clin Orthop 122: 70-76.
3. Barwood S, Baillieu C, Boyd R. (2000) Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol 42: 116-121.
4. Betts RP, Franks CI, Duckworth T, Burke J. (1980) Static and dynamic foot pressure measurements in clinical orthopaedics. Med Biol Eng Comput 18: 674-684.
5. Bohannon R, Smith M. (1987) Interrater reliability of modified Ashworth scale of muscle spasticity. Phys Ther 67: 206-207.
6. Boulton AJ, Hardisty CA, Betts RP, Franks CI, Worth RC, Ward JD, Duckworth T. (1983) Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 6: 26-33.
7. Boyd RN, Pliatsios V, Starr R. (2000) Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol 42: 32-41.
8. Burbaud P, Wiart L, Dubos JL, Dubos JL, Gaujard E, Debelleix X, Joseph PA, Mazaux JM, Bioulac B, Barat M, Lageny A. (1996) A randomized, double-blind, placebo-controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 61: 265-269.
9. Cavanagh PR, Rodgers MM, Iiboshi A. (1987) Pressure distribution under symptoms free feet during barefoot standing. Foot Ankle 7: 262-276.
10. Chang AH, Abu-Faraj ZU, Harris GF, Nery J, Shereff MJ. (1994) Multistep measurement of plantar pressure alterations using metatarsal pads. Foot Ankle 15: 654-660.
11. Corry IS, Cosgrove AP, Duffy CM. (1999) Botulinum toxin A in hamstring spasticity. Gait Posture 10: 206-210.
12. Cosgrove AP, Corry IS, Graham HK. (1994) Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 36: 386-396.
13. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH. (1992) Local botulinum toxin in the treatment of spastic drop foot. J Neurol 239: 375-378.
14. Duckworth T, Boulton AJM, Betts RP, Franks CI, Ward JD. (1985) Plantar pressure measurements and the prevention of ulceration in the diabetic foot. J Bone Joint Surg 67: 79-85.
15. Eames NW, Baker R, Hill N, Graham HK, Cosgrove AP. (1999) The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Dev Med Child Neurol 41: 226-232.
16. Fehlings D, Rang M, Glazier J. (2000) An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Paediatr 137: 331-337.
17. Flynn TW, Canavan PK, Cavanagh PR, Chiang JH. (1997) Plantar pressure reduction in an incremental weight-bearing system. Phys Ther 77: 410-416.
18. Grieve DW, Rashdi T. (1984) Pressures under normal feet in standing and walking as measured by foil pedobarography. Ann Rheum Dis 43: 816-818.
19. Hamill J, Bates BT, Knutzen KM. (1983) Ground reaction force symmetry during walking and running. Med Sci Sports Exercise 15: 170. (Abstract)
20. Hesse S, Luecke D, Malezic M, Bertelt C, Friedrich H, Gregoric M, Mauritz KH. (1994) Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 57: 1321-1324.
21. Hughes J. (1993) The clinical use of pedobarography. Acta Orthop Belg 59: 10-16.
22. Hughes J, Clark P, Linge K, Klenerman L. (1993) A comparison of two studies of the pressure distribution under the feet of normal subjects using different equipment. Foot Ankle 14: 514-519.
23. Hughes J, Pratt L, Linge K, Clark P, Klenerman L. (1990) Reliability of pressure measurements: the EMED F system. Clin Biomech (Bristol, Avon) 6: 14-18.
24. Imamura M, Imamura ST, Salomao O, Pereira CAM, De Carvalho Jr AE, Bolliger Neto R. (2002) Pedobarometric evaluation of the normal adult male foot. Foot Ankle Int 23: 804-810.
25. Kirschner J, Berweck S, Mall V, Korinthenberg R, Heinen F. (2001) Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option. J Neurol 248: 28-30.
26. Koman LA, Mooney JF, III, Smith BP. (2000) Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. Botox Study Group. J Pediatr Orthop 20: 108-115.
27. Metaxiotis D, Siebel A, Doederlein L. (2002) Repeated botulinum toxin A injections in the treatment of spastic equinus foot. Clin Orthop 394: 177-185.
28. Minns RJ, Craxford AD. (1984) Pressure under the forefoot in rheumatoid arthritis. A comparison of static and dynamic methods of assessment. Clin Orthop 187: 235-242.
29. Polak F, Morton R, Ward WA, Doderlein L, Siebel A. (2002) Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy. Dev Med Child Neurol 44: 551-555.
30. Quaney B, Meyer K, Cornwall MW, McPoil TG. (1995) A comparison of the dynamic pedobarograph and EMED systems for measuring dynamic foot pressures. Foot Ankle Int 16: 562-566.
31. Sarnow MR, Veves A, Giurini JM, Rosenblum BI, Chrzan JS, Habershaw GM. (1994) In-shoe foot pressure measurements in diabetic patients with at-risk feet and healthy subjects. Diabetes Care 17: 1002-1006.
32. Schaff PS. (1993) An overview of foot pressure measurement systems. Clin Podiatr Med Surg 10: 403-415.
33. Sutherland DH, Kaufman KR, Wyatt MP. (1996) Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy: a 3-dimensional motion analysis study. Gait Posture 10: 269-279.
34. Tardieu G, Tardieu C. (1987) Cerebral palsy: mechanical evaluation and conservative correction of limb joint contractures. Clin Orthop 219: 63-69.
35. Veves A, Sarnow MR, Giurini JM, Rosenblum BI, Lyons TE, Chrzan JS, Habershaw GM. (1995) Differences in joint mobility and foot pressures between black and white diabetic patients. Diabet Med 12: 585-589.
36. Zuercher AW, Molenaers G, Desloovere K, Fabry G. (2001) Kinematic and kinetic evaluation of the ankle after intramuscular injection of botulinum toxin A in children with cerebral palsy. Acta Orthop Belg 67: 475-480.